KG
Kathryn Guarini (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $360K of REGN (400 sh × $900.00, as filed), executed Oct 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.0M
shares × price, as filed
Last traded
Oct 30
Filed Nov 3
Median ADV $702.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
REGNRecent filings
REGNSALE
Regeneron Pharmaceuticals, Inc.
View filing →
$360K400 sh × $900.00
Exec Oct 30
Filed Nov 3 · 4:22 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $340K
400 sh × $850.00
Exec Sep 2
Filed Sep 3 · 4:47 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $320K
400 sh × $800.00
Exec Aug 10
Filed Aug 12 · 4:16 PM ET